Nuvation Change To Inventory from 2010 to 2026
| NUVB Stock | USD 5.72 0.01 0.18% |
Change To Inventory | First Reported 2010-12-31 | Previous Quarter -498.6 K | Current Value -473.7 K | Quarterly Volatility 594.9 K |
Check Nuvation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvation Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 645.4 K, Interest Expense of 372.5 K or Selling General Administrative of 80.6 M, as well as many indicators such as Price To Sales Ratio of 72.65, Dividend Yield of 0.0 or PTB Ratio of 1.46. Nuvation financial statements analysis is a perfect complement when working with Nuvation Bio Valuation or Volatility modules.
Nuvation | Change To Inventory | Build AI portfolio with Nuvation Stock |
Analyzing Nuvation Bio's Change To Inventory over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change To Inventory has evolved provides context for assessing Nuvation Bio's current valuation and future prospects.
Latest Nuvation Bio's Change To Inventory Growth Pattern
Below is the plot of the Change To Inventory of Nuvation Bio over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Nuvation Bio's Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuvation Bio's overall financial position and show how it may be relating to other accounts over time.
| Change To Inventory | 10 Years Trend |
|
Change To Inventory |
| Timeline |
Nuvation Change To Inventory Regression Statistics
| Arithmetic Mean | 130,396 | |
| Coefficient Of Variation | 456.21 | |
| Mean Deviation | 386,618 | |
| Median | 264,000 | |
| Standard Deviation | 594,881 | |
| Sample Variance | 353.9B | |
| Range | 2.5M | |
| R-Value | (0.38) | |
| Mean Square Error | 321.8B | |
| R-Squared | 0.15 | |
| Significance | 0.13 | |
| Slope | (45,246) | |
| Total Sum of Squares | 5.7T |
Nuvation Change To Inventory History
About Nuvation Bio Financial Statements
Nuvation Bio stakeholders use historical fundamental indicators, such as Nuvation Bio's Change To Inventory, to determine how well the company is positioned to perform in the future. Although Nuvation Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nuvation Bio's assets and liabilities are reflected in the revenues and expenses on Nuvation Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nuvation Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change To Inventory | -498.6 K | -473.7 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:Check out the analysis of Nuvation Bio Correlation against competitors. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. Anticipated expansion of Nuvation directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nuvation Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.49) | Revenue Per Share | Quarterly Revenue Growth 17.047 | Return On Assets | Return On Equity |
Understanding Nuvation Bio requires distinguishing between market price and book value, where the latter reflects Nuvation's accounting equity. The concept of intrinsic value - what Nuvation Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Nuvation Bio's price substantially above or below its fundamental value.
It's important to distinguish between Nuvation Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nuvation Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Nuvation Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.